Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 11, 2013, Pages 1461-1464

  Biswas, S ^a   Dubus, J C ^a   Reynaud Gaubert, M ^a   Stremler, N ^a   Rolain, J M ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CYSTIC FIBROSIS; DISK DIFFUSION; EPSILOMETER TEST; FRANCE; GRAM NEGATIVE BACTERIUM; HUMAN; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STENOTROPHOMONAS MALTOPHILIA;

ACHROMOBACTER DENITRIFICANS; ANTI-BACTERIAL AGENTS; COLISTIN; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FRANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; STENOTROPHOMONAS MALTOPHILIA;

EID: 84886594095     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1898-5     Document Type: Article

References (25)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073
2. Rosenstein BJ, Zeitlin PL (1998) Cystic fibrosis. Lancet 351:277-282
3. Klinger JD, Thomassen MJ (1985) Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis 3:149-158
4. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194-222
5. Miller MB, Gilligan PH (2003) Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 41:4009-4015
6. Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008-1011
7. Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP et al (2000) A ten year review of colomycin. Respir Med 94:632-640
8. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L et al (1998) Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27:158-163
9. Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J (2004) Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 54:1057-1061
10. Spencer RC (1995) The emergence of epidemic, multiple-antibiotic- resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 30(Suppl):453-464
11. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement, M100-S22. CLSI, Wayne
12. Ballestero S, Vírseda I, Escobar H, Suárez L, Baquero F (1995) Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 14:728-729
13. Denton M, Kerr KG (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57-80
14. Palleroni NJ, Bradbury JF (1993) Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol 43:606-609
15. Andrews JM; BSAC Working Party On Susceptibility Testing ft (2001) BSAC standardized disc susceptibility testing method. J Antimicrob Chemother 48(Suppl 1):43-57
16. Members of the SFM Antibiogram Committee (2003) Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 21:364-391
17. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K (2005) Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25:11-25
18. Nicodemo AC, Araujo MR, Ruiz AS, Gales AC (2004) In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother 53:604-608
19. Moskowitz SM, Garber E, Chen Y, Clock SA, Tabibi S, Miller AK et al (2010) Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Antimicrob Chemother 65:1416-1423
20. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J (2011) Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros 10:422-427
21. Somily AM (2010) Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli. Saudi Med J 31:507-511
22. Gülmez D, Cakar A, Sener B, Karakaya J, Hasçelik G (2010) Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing. J Infect Chemother 16:322-328
23. Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H (2008) Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents 31:434-439
24. Tan TY, Ng SY (2007) Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 13:541-544
25. Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183-190